{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:00:40Z","timestamp":1780380040389,"version":"3.54.1"},"reference-count":177,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"am","delay-in-days":256,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jaci.2022.11.010","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T15:23:06Z","timestamp":1670944986000},"page":"818-831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity"],"prefix":"10.1016","volume":"151","author":[{"given":"Stuart G.","family":"Tangye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"Al-Muhsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Aiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"Al-Muhsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahd","family":"Al-Mulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Andreakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s A.","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit Baris","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Belot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Biggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Bousfiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"Brodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Condino-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifton L.","family":"Dalgard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Espinosa-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Fellay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Froidure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomeen","family":"Haerynck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabih","family":"Halwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Henrickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena W.Y.","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuval","family":"Itan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timokratis","family":"Karamitros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lung","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Meyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine H.","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Morio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa F.P.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayfun","family":"Ozcelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Pan-Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Perez de Diego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Prando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Renia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rodr\u00edguez-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Sancho-Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko R.J.","family":"Sepp\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Shcherbina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Snow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Soler-Palac\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s N.","family":"Spaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Tancevski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart G.","family":"Tangye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Abou","family":"Tayoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehime G.","family":"Temel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart E.","family":"Turvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed J.","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C.","family":"Vinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayana","family":"Zatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Pelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Pesole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederik","family":"van de Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Colobran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Wauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen C.","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2022.11.010_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.smim.2017.12.008","article-title":"Human genetics of infectious diseases: unique insights into immunological redundancy","volume":"36","author":"Casanova","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib2","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/j.cell.2022.07.004","article-title":"From rare disorders of immunity to common determinants of infection: following the mechanistic thread","volume":"185","author":"Casanova","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2022.11.010_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.smim.2017.12.001","article-title":"What do primary immunodeficiencies tell us about the essentiality\/redundancy of immune responses?","volume":"36","author":"Fischer","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb1662","article-title":"Human inborn errors of immunity: an expanding universe","author":"Notarangelo","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.coi.2017.09.002","article-title":"Pathogenesis of infections in HIV-infected individuals: insights from primary immunodeficiencies","volume":"48","author":"Zhang","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib7","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1126\/science.1260791","article-title":"Immunology. Autoimmunity by haploinsufficiency","volume":"345","author":"Rieux-Laucat","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jaci.2022.11.010_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.coi.2021.05.010","article-title":"There is no gene for CVID\u2014novel monogenetic causes for primary antibody deficiency","volume":"72","author":"Ramirez","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s10875-019-00642-3","article-title":"Life-threatening infections due to live-attenuated vaccines: early manifestations of inborn errors of immunity","volume":"39","author":"Poyhonen","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib10","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jaci.2021.04.015","article-title":"Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations","volume":"148","author":"Thalhammer","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib11","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","article-title":"Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies","volume":"140","author":"Fischer","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib12","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.jaip.2019.07.026","article-title":"Redefining precision medicine in disorders of immune dysregulation","volume":"7","author":"Leiding","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.11.010_bib13","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200537","article-title":"Forty years with coronaviruses","author":"Weiss","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib15","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaci.2020.12.620","article-title":"COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience","volume":"147","author":"Shields","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.15585\/mmwr.mm6924e2","article-title":"Coronavirus disease 2019 case surveillance\u2014United States, January 22-May 30, 2020","volume":"69","author":"Stokes","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2022.11.010_bib17","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2022.11.010_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","volume":"146","author":"Li","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib19","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.12.2000256","article-title":"Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship","volume":"25","author":"Russell","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jaci.2022.11.010_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144455","article-title":"An immune-based biomarker signature is associated with mortality in COVID-19 patients","volume":"6","author":"Abers","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2022.11.010_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib23","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib24","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jaci.2022.11.010_bib25","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1002\/jmv.26149","article-title":"Higher levels of IL-6 early after tocilizumab distinguish survivors from nonsurvivors in COVID-19 pneumonia: a possible indication for deeper targeting of IL-6","volume":"92","author":"Quartuccio","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.jaci.2022.11.010_bib26","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib27","doi-asserted-by":"crossref","first-page":"25018","DOI":"10.1073\/pnas.2010540117","article-title":"Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients","volume":"117","author":"Holter","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.11.010_bib28","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41591-020-1021-2","article-title":"Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection","volume":"26","author":"Ramlall","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib29","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.11.010_bib30","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.jaci.2021.09.008","article-title":"Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection","volume":"148","author":"Hou","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib31","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202515","article-title":"Persistent cellular immunity to SARS-CoV-2 infection","author":"Breton","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","author":"Dan","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jaci.2022.11.010_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf7517","article-title":"T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals","author":"Bilich","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib34","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.immuni.2021.06.015","article-title":"Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants","volume":"54","author":"Moriyama","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2022.11.010_bib35","first-page":"281","article-title":"Persistence of SARS-CoV-2\u2013specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection","volume":"2","author":"Sherina","year":"2021","journal-title":"Med (N Y)"},{"key":"10.1016\/j.jaci.2022.11.010_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf8891","article-title":"Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence","volume":"5","author":"Hartley","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib37","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1126\/science.abd7728","article-title":"Robust neutralizing antibodies to SARS-CoV-2 infection persist for months","volume":"370","author":"Wajnberg","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jaci.2022.11.010_bib38","doi-asserted-by":"crossref","first-page":"110345","DOI":"10.1016\/j.celrep.2022.110345","article-title":"Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2\u2013specific CD4+ T cell responses","volume":"38","author":"Balachandran","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2022.11.010_bib39","doi-asserted-by":"crossref","first-page":"100228","DOI":"10.1016\/j.xcrm.2021.100228","article-title":"Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection","volume":"2","author":"Abayasingam","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib40","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/S2666-5247(21)00025-2","article-title":"Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study","volume":"2","author":"Chia","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jaci.2022.11.010_bib41","doi-asserted-by":"crossref","first-page":"781429","DOI":"10.3389\/fcimb.2021.781429","article-title":"SARS-COV-2 variants: differences and potential of immune evasion","volume":"11","author":"Hirabara","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jaci.2022.11.010_bib42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10875-022-01215-7","article-title":"Inherited IFNAR1 deficiency in a child with both critical COVID-19 pneumonia and multisystem inflammatory syndrome","volume":"42","author":"Abolhassani","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib43","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jaci.2020.09.020","article-title":"Severe SARS-CoV-2 disease in the context of a NF-kappaB2 loss-of-function pathogenic variant","volume":"147","author":"Abraham","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib44","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s40618-020-01323-4","article-title":"A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor","volume":"43","author":"Beccuti","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jaci.2022.11.010_bib45","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s10875-022-01240-6","article-title":"A novel kindred with MyD88 deficiency","volume":"42","author":"Bucciol","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib46","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1038\/s41467-020-19761-2","article-title":"Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report","volume":"11","author":"Buckland","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2022.11.010_bib47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/pai.13322","article-title":"A male infant with COVID-19 in the context of ARPC1B deficiency","volume":"32","author":"Castano-Jaramillo","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib48","doi-asserted-by":"crossref","first-page":"603428","DOI":"10.3389\/fimmu.2020.603428","article-title":"Mild SARS-CoV-2 infection after gene therapy in a child with Wiskott-Aldrich syndrome: a case report","volume":"11","author":"Cenciarelli","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib49","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-021-01093-5","article-title":"Self-limited COVID-19 in a patient with artemis hypomorphic SCID","author":"Gabryszewski","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib50","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-021-01081-9","article-title":"SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under ruxolitinib therapy\u2014a matter of balance?","author":"Guisado Hernandez","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib51","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-022-01256-y","article-title":"SARS-CoV-2\u2013specific and functional cytotoxic CD8 cells in primary antibody deficiency: natural infection and response to vaccine","author":"Gupta","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000514193","article-title":"SARS-CoV-2\u2013associated T-cell responses in the presence of humoral immunodeficiency","volume":"182","author":"Gupta","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib53","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10875-021-00983-y","article-title":"A patient with X-linked agammaglobulinemia and COVID-19 infection treated with remdesivir and convalescent plasma","volume":"41","author":"Iaboni","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib54","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaip.2020.08.053","article-title":"IFN-gamma receptor 2 deficiency initial mimicry of multisystem inflammatory syndrome in children (MIS-C)","volume":"9","author":"Jin","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.11.010_bib55","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1016\/j.jaip.2020.08.059","article-title":"Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma","volume":"8","author":"Jin","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.11.010_bib56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10875-021-01166-5","article-title":"A case of autosomal recessive interferon alpha\/beta receptor alpha chain (IFNAR1) deficiency with severe COVID-19","volume":"42","author":"Khanmohammadi","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib57","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jaci.2021.03.034","article-title":"Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis","volume":"148","author":"Lemarquis","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib58","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s10875-020-00904-5","article-title":"Severe COVID-19 in patients with B cell alymphocytosis and response to convalescent plasma therapy","volume":"41","author":"London","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10875-020-00896-2","article-title":"Recovery from COVID-19 in a child with chronic granulomatous disease and T cell lymphopenia","volume":"41","author":"Mantravadi","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib60","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3855\/jidc.13840","article-title":"Atypical course of COVID-19 in patient with Bruton agammaglobulinemia","volume":"14","author":"Milosevic","year":"2020","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.jaci.2022.11.010_bib61","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.jaip.2020.06.046","article-title":"Rapid recovery of a SARS-CoV-2\u2013infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma","volume":"8","author":"Mira","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.11.010_bib62","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.anai.2020.08.017","article-title":"A fatal case of coronavirus disease 2019 in a patient with common variable immunodeficiency","volume":"126","author":"Mullur","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib63","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-022-01316-3","article-title":"Post\u2013SARS-CoV-2 atypical inflammatory syndrome in a toddler with X-linked inhibitor of apoptosis deficiency after stem cell transplant","author":"Narahari","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib64","doi-asserted-by":"crossref","first-page":"881259","DOI":"10.3389\/fimmu.2022.881259","article-title":"Case report: a severe paediatric presentation of COVID-19 in APDS2 immunodeficiency","volume":"13","author":"Sanchez Clemente","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41525-021-00220-w","article-title":"TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19","volume":"6","author":"Schmidt","year":"2021","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib66","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/pai.13263","article-title":"Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover","volume":"31","author":"Soresina","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib67","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s10875-021-01054-y","article-title":"SARS-CoV-2 infection in a child with severe congenital neutropenia","volume":"41","author":"Vignesh","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10875-020-00933-0","article-title":"IFN-alpha2a therapy in two patients with inborn errors of TLR3 and IRF3 infected with SARS-CoV-2","volume":"41","author":"Levy","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib69","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2114390118","article-title":"Monoclonal antibody\u2013mediated neutralization of SARS-CoV-2 in an IRF9-deficient child","author":"Levy","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.11.010_bib70","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-021-01063-x","article-title":"SARS-CoV-2\u2013related acute respiratory distress syndrome uncovers a patient with severe combined immunodeficiency disease","author":"Al-Saud","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib71","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.anai.2020.06.006","article-title":"Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin","volume":"125","author":"Aljaberi","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib72","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12026-021-09184-6","article-title":"Management of COVID-19 pneumonia in a child with NEMO deficiency","volume":"69","author":"Alkan","year":"2021","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaci.2022.11.010_bib73","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.929447","article-title":"The clinical course of COVID-19 pneumonia in a 19-year-old man on intravenous immunoglobulin replacement therapy for X-linked agammaglobulinemia","volume":"22","author":"Almontasheri","year":"2021","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.jaci.2022.11.010_bib74","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-021-01076-6","article-title":"SARS-CoV-2 infection inducing severe flare up of deficiency of interleukin thirty-six (IL-36) receptor antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist","author":"Bozonnat","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib75","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.anai.2020.04.033","article-title":"The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019","volume":"125","author":"Fill","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib76","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaci.2020.07.033","article-title":"Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1","volume":"146","author":"Lee","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib77","doi-asserted-by":"crossref","first-page":"108662","DOI":"10.1016\/j.clim.2020.108662","article-title":"SARS-CoV-2 infection associated with hepatitis in an infant with X-linked severe combined immunodeficiency","volume":"224","author":"van Oers","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib78","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10875-021-01023-5","article-title":"Interferon-beta therapy in a patient with incontinentia pigmenti and autoantibodies against type I IFNs infected with SARS-CoV-2","volume":"41","author":"Bastard","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib79","article-title":"Mendelian susceptibility to mycobacterial disease: retrospective clinical and genetic study in Mexico","author":"Penafiel Vicuna","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib80","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s10875-021-01163-8","article-title":"Immunogenicity and safety of COVID-19 mRNA vaccine in STAT1 GOF patients","volume":"42","author":"Bloomfield","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib81","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1542\/peds.147.3MA5.453","article-title":"Varying Illness severity in patients with MyD88 deficiency infected with coronavirus SARS-CoV-2","volume":"147","author":"Mahmood","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2022.11.010_bib82","doi-asserted-by":"crossref","first-page":"891274","DOI":"10.3389\/fimmu.2022.891274","article-title":"Case report: successful treatment with monoclonal antibodies in one apds patient with prolonged SARS-CoV-2 infection not responsive to previous lines of treatment","volume":"13","author":"Rivalta","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib83","doi-asserted-by":"crossref","first-page":"840126","DOI":"10.3389\/fimmu.2022.840126","article-title":"SARS-CoV-2 T cell response in severe and fatal COVID-19 in primary antibody deficiency patients without specific humoral immunity","volume":"13","author":"Steiner","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib84","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10875-022-01245-1","article-title":"Diagnosis of APS-1 in two siblings following life-threatening COVID-19 pneumonia","volume":"42","author":"Schidlowski","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib85","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijid.2021.07.064","article-title":"Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia","volume":"110","author":"Palomba","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jaci.2022.11.010_bib86","article-title":"Bruton\u2019s agammaglobulinemia and COVID-19","volume":"12","author":"Hovey","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jaci.2022.11.010_bib87","first-page":"219","article-title":"Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic","author":"Duncan","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib88","article-title":"A rare STXBP2 mutation in severe COVID-19 and secondary cytokine storm syndrome","volume":"12","author":"Reiff","year":"2022","journal-title":"Life (Basel)"},{"key":"10.1016\/j.jaci.2022.11.010_bib89","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10875-020-00928-x","article-title":"Impact of SARS-CoV-2 pandemic on patients with primary immunodeficiency","volume":"41","author":"Delavari","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-021-01151-y","article-title":"X-linked TLR7 deficiency underlies critical COVID-19 pneumonia in a male patient with ataxia-telangiectasia","volume":"42","author":"Abolhassani","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2022.09.005","article-title":"Genetic and immunological evaluation of children with inborn errors of immunity and severe or critical COVID-19","author":"Abolhassani","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib92","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-021-01065-9","article-title":"COVID-19 in patients with primary immunodeficiency","author":"Esenboga","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib93","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00296-021-04812-8","article-title":"COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study","volume":"41","author":"Guven","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaci.2022.11.010_bib94","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/all.15025","article-title":"Adverse COVID-19 outcomes in immune deficiencies: inequality exists between subclasses","volume":"77","author":"Karakoc Aydiner","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.11.010_bib95","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-021-01066-8","article-title":"Outcome of SARS-CoV-2 infection in 121 patients with inborn errors of immunity: a cross-sectional study","author":"Goudouris","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib96","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jaip.2020.11.042","article-title":"COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency","volume":"9","author":"Grumach","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.11.010_bib97","doi-asserted-by":"crossref","first-page":"614086","DOI":"10.3389\/fimmu.2020.614086","article-title":"Minor clinical impact of COVID-19 pandemic on patients with primary immunodeficiency in Israel","volume":"11","author":"Marcus","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib98","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jaci.2020.04.013","article-title":"A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia","volume":"146","author":"Quinti","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib99","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/j.jaip.2021.04.017","article-title":"Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity","volume":"9","author":"Milito","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.11.010_bib100","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-022-01264-y","article-title":"The impact of SARS-CoV-2 infection in patients with inborn errors of immunity: the experience of the Italian Primary Immunodeficiencies Network (IPINet)","author":"Giardino","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib101","series-title":"Mortality in severe antibody deficiencies patients during the first two years of the COVID-19 pandemic: vaccination and monoclonal antibodies efficacy","author":"Milito","year":"2022"},{"key":"10.1016\/j.jaci.2022.11.010_bib102","doi-asserted-by":"crossref","first-page":"108821","DOI":"10.1016\/j.clim.2021.108821","article-title":"COVID-19 in children and young adults with moderate\/severe inborn errors of immunity in a high burden area in pre-vaccine era","volume":"230","author":"Deya-Martinez","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib103","doi-asserted-by":"crossref","DOI":"10.1093\/cei\/uxac008","article-title":"Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK","author":"Shields","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib104","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jaci.2021.10.031","article-title":"Treatment of chronic or relapsing COVID-19 in immunodeficiency","volume":"149","author":"Brown","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib105","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-021-01077-5","article-title":"COVID-19 in the context of inborn errors of immunity: a case series of 31 patients from Mexico","author":"Castano-Jaramillo","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib106","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1080\/23744235.2021.1957144","article-title":"Low morbidity in Danish patients with common variable immunodeficiency disorder infected with severe acute respiratory syndrome coronavirus 2","volume":"53","author":"Drabe","year":"2021","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.jaci.2022.11.010_bib107","doi-asserted-by":"crossref","first-page":"994253","DOI":"10.3389\/fimmu.2022.994253","article-title":"Outcome of SARS-CoV-2 infection among patients with common variable immunodeficiency and a matched control group: a Danish nationwide cohort study","volume":"13","author":"Katzenstein","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib108","doi-asserted-by":"crossref","first-page":"953700","DOI":"10.3389\/fimmu.2022.953700","article-title":"COVID-19 in unvaccinated patients with inborn errors of immunity-polish experience","volume":"13","author":"Koltan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib109","doi-asserted-by":"crossref","first-page":"835770","DOI":"10.3389\/fimmu.2022.835770","article-title":"Risk factors for severe COVID-19 and hospital admission in patients with inborn errors of immunity\u2014results from a multicenter nationwide study","volume":"13","author":"Milota","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib110","article-title":"Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area","author":"Bourguiba","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2022.11.010_bib111","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaip.2020.09.052","article-title":"Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City","volume":"9","author":"Ho","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.11.010_bib112","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jaip.2020.11.006","article-title":"COVID-19 infection in 10 common variable immunodeficiency patients in New York City","volume":"9","author":"Cohen","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.11.010_bib113","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10875-021-01150-z","article-title":"COVID-19 in CVID: a case series of 17 patients","volume":"42","author":"Greenmyer","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib114","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaip.2021.11.030","article-title":"Low IgG trough and lymphocyte subset counts are associated with hospitalization for COVID-19 in patients with primary antibody deficiency","volume":"10","author":"Kuster","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.11.010_bib115","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2020.09.010","article-title":"Coronavirus disease 2019 in patients with inborn errors of immunity: an international study","volume":"147","author":"Meyts","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib116","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.jaip.2022.05.004","article-title":"SARS-CoV-2 symptomatic reinfection among patients with primary antibody deficiency","volume":"10","author":"Marcus","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.11.010_bib117","doi-asserted-by":"crossref","first-page":"958658","DOI":"10.3389\/fped.2022.958658","article-title":"Risk factors for severe COVID-19 in people with cystic fibrosis: a systematic review","volume":"10","author":"Terlizzi","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaci.2022.11.010_bib118","first-page":"218","article-title":"Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1","author":"Bastard","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib119","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/ACI.0000000000000786","article-title":"Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity","volume":"21","author":"Tangye","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib120","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jaci.2022.11.010_bib121","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211387","article-title":"Human autoantibodies underlying infectious diseases","author":"Puel","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib122","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150867","article-title":"Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1","author":"Meisel","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.11.010_bib123","article-title":"Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency","author":"Campbell","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib124","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jama.2020.13719","article-title":"Presence of genetic variants among young men with severe COVID-19","volume":"324","author":"van der Made","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2022.11.010_bib125","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4348","article-title":"X-linked recessive TLR7 deficiency in \u223c1% of men under 60 years old with life-threatening COVID-19","author":"Asano","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib126","article-title":"Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia","author":"Zhang","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib127","article-title":"Human genetic and immunological determinants of critical COVID-19 pneumonia","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2022.11.010_bib128","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jaci.2022.11.010_bib129","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s10875-021-01036-0","article-title":"Neutralizing autoantibodies to type I IFNs in >10% of patients with severe COVID-19 pneumonia hospitalized in Madrid, Spain","volume":"41","author":"Troya","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib130","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in \u223c4% of uninfected individuals over 70 years and account for \u223c20% of COVID-19 deaths","author":"Bastard","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib131","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s10875-021-00994-9","article-title":"Plasma exchange to rescue patients with autoantibodies against type I interferons and life-threatening COVID-19 pneumonia","volume":"41","author":"de Prost","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib132","doi-asserted-by":"crossref","DOI":"10.1111\/imcb.12495","article-title":"Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19","author":"Abers","year":"2021","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaci.2022.11.010_bib133","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200413119","article-title":"The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies","volume":"119","author":"Manry","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.11.010_bib134","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-022-01308-3","article-title":"Neutralizing type I Interferon autoantibodies in Japanese patients with severe COVID-19","author":"Eto","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib135","doi-asserted-by":"crossref","first-page":"eabh2624","DOI":"10.1126\/scitranslmed.abh2624","article-title":"Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19","volume":"13","author":"van der Wijst","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib136","doi-asserted-by":"crossref","first-page":"e1327","DOI":"10.1002\/cti2.1327","article-title":"Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients","volume":"10","author":"Goncalves","year":"2021","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.jaci.2022.11.010_bib137","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s10875-021-01168-3","article-title":"Interferon-alpha2 auto-antibodies in convalescent plasma therapy for COVID-19","volume":"42","author":"Raadsen","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib138","doi-asserted-by":"crossref","DOI":"10.1136\/ard-2022-222549","article-title":"Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-alpha","author":"Mathian","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2022.11.010_bib139","doi-asserted-by":"crossref","first-page":"100089","DOI":"10.1016\/j.clinpr.2021.100089","article-title":"Compassionate use of REGN-COV2 in the treatment of COVID-19 in a patient with impaired humoral immunity","volume":"12","author":"Nguyen","year":"2021","journal-title":"Clin Infect Pract"},{"key":"10.1016\/j.jaci.2022.11.010_bib140","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-240765","article-title":"Possible COVID-19 reinfection in a patient with X-linked agammaglobulinaemia","author":"Loh","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaci.2022.11.010_bib141","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00296-021-04969-2","article-title":"Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed","volume":"41","author":"Daoussis","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaci.2022.11.010_bib142","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00296-020-04699-x","article-title":"High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study","volume":"40","author":"Loarce-Martos","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaci.2022.11.010_bib143","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10875-021-01193-2","article-title":"Case series: convalescent plasma therapy for patients with COVID-19 and primary antibody deficiency","volume":"42","author":"Lang-Meli","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib144","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jaci.2013.12.1085","article-title":"Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation","volume":"133","author":"Lougaris","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib145","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1182\/blood.2020006288","article-title":"The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19\u2013infected patients","volume":"135","author":"Treon","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.11.010_bib146","first-page":"5","article-title":"Inhibition of Bruton tyrosine kinase in patients with severe COVID-19","author":"Roschewski","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib147","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10875-020-00911-6","article-title":"Tocilizumab for severe worsening COVID-19 pneumonia: a propensity score analysis","volume":"41","author":"Roumier","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102567","article-title":"Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions","volume":"19","author":"Jamilloux","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaci.2022.11.010_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.720205","article-title":"SARS-CoV-2 spike protein\u2013directed monoclonal antibodies may ameliorate COVID-19 complications in APECED patients","volume":"12","author":"Ferr\u00e9","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib150","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra2206573","article-title":"COVID-19 vaccines\u2014immunity, variants, boosters","volume":"387","author":"Barouch","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib151","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/imr.13089","article-title":"Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines","volume":"310","author":"Sette","year":"2022","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2022.11.010_bib152","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2022.11.010_bib153","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1056\/NEJMoa2114114","article-title":"Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar","volume":"385","author":"Chemaitelly","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib154","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib155","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2021.12.027","article-title":"Transmission from vaccinated individuals in a large SARS-CoV-2 Delta variant outbreak","volume":"185","author":"Siddle","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2022.11.010_bib156","doi-asserted-by":"crossref","first-page":"veac050","DOI":"10.1093\/ve\/veac050","article-title":"Recurrent SARS-CoV-2 mutations in immunodeficient patients","volume":"8","author":"Wilkinson","year":"2022","journal-title":"Virus Evol"},{"key":"10.1016\/j.jaci.2022.11.010_bib157","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jaci.2022.11.010_bib158","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.727850","article-title":"Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies","volume":"12","author":"Amodio","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.895209","article-title":"Evaluation of humoral and cellular immune responses to the SARS-CoV-2 vaccine in patients with common variable immunodeficiency phenotype and patient receiving B-cell depletion therapy","volume":"13","author":"Antoli","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib160","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10875-021-01174-5","article-title":"Immunogenicity of anti\u2013SARS-CoV-2 vaccines in common variable immunodeficiency","volume":"42","author":"Arroyo-Sanchez","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib161","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jaip.2022.03.017","article-title":"Response to severe acute respiratory syndrome coronavirus 2 initial series and additional dose vaccine in patients with predominant antibody deficiency","volume":"10","author":"Barmettler","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.11.010_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103705","article-title":"Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial","volume":"74","author":"Bergman","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaci.2022.11.010_bib163","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s10875-022-01244-2","article-title":"Elevated CD21low B cell frequency is a marker of poor immunity to Pfizer-BioNTech BNT162b2 mRNA vaccine against SARS-CoV-2 in patients with common variable immunodeficiency","volume":"42","author":"Bergman","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib164","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-022-01251-3","article-title":"Responses to SARS-CoV-2 vaccines of patients with common variable immune deficiencies and X-linked agammaglobulinemia","author":"Carrabba","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib165","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jaci.2021.08.016","article-title":"Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity","volume":"148","author":"Delmonte","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2021.05.029","article-title":"Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity","author":"Hagin","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib167","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jaci.2021.11.022","article-title":"Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects","volume":"149","author":"Pham","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib168","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s10875-022-01223-7","article-title":"COVID-19 vaccine uptake and efficacy in a national immunodeficiency cohort","volume":"42","author":"Ponsford","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib169","series-title":"B cell response induced by SARS-CoV-2 infection is boosted by the BNT162b2 vaccine in primary antibody deficiencies","author":"Pulvirenti","year":"2021"},{"key":"10.1016\/j.jaci.2022.11.010_bib170","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.anai.2021.07.026","article-title":"Detection of neutralizing anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with common variable immunodeficiency after immunization with messenger RNA vaccines","volume":"127","author":"Romano","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib171","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s10875-021-01133-0","article-title":"SARS-CoV-2 vaccine induced atypical immune responses in antibody defects: everybody does their best","volume":"41","author":"Salinas","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib172","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-022-01231-7","article-title":"SARS-CoV-2 vaccine responses in individuals with antibody deficiency: findings from the COV-AD study","author":"Shields","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib173","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jaci.2022.04.002","article-title":"Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity","volume":"149","author":"van Leeuwen","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib174","article-title":"Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination","author":"Sokal","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.11.010_bib175","article-title":"Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs","author":"Bastard","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib176","article-title":"Clinical outcomes of SARS-CoV2 infection in STAT3 deficiency","volume":"41","author":"Khalid","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.010_bib177","article-title":"COVID-19 in 3 patients with CTLA4 haploinsufficiency and absence of autoantibodies to type 1 interferons","author":"Ochoa","year":"2021","journal-title":"J Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922015688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922015688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:43:45Z","timestamp":1758793425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674922015688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":177,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0091674922015688"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2022.11.010","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2022.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}